Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory

被引：0
|
作者：
Hristova, Mariyana [1 ]
机构：
[1] Med Ctr Varna, Div Endocrinol, Varna, Bulgaria
来源：
MEDICAL HYPOTHESES | 2017年 / 102卷
关键词：
TYPE-2; DIABETES-MELLITUS; METABOLIC SYNDROME; SGLT2; INHIBITORS; BLOOD-PRESSURE; KIDNEY-DISEASE; HYPOTHESIS; OUTCOMES; DAPAGLIFLOZIN; REABSORPTION; METAANALYSIS;
D O I：
10.1016/j.mehy.2017.02.021
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：61 / 64
页数：4
相关论文
共 50 条
  • [1] Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
    Yang Fan
    Meng Ran
    Zhu Da-Long
    慢性疾病与转化医学（英文）, 2020, 06 (04) : 239 - 245
  • [2] The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors
    Tanna, Monique S.
    Goldberg, Lee R.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (06) : 764 - 768
  • [3] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease
    Aftab, Saba
    Suresh, Rishwanth Vetrivel
    Sherali, Nazleen
    Daniyal, Muhammad
    Tsouklidis, Nicholas
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [4] Potential Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in the Perioperative Period
    Hulst, Abraham H.
    Hermanides, Jeroen
    DeVries, J. Hans
    Preckel, Benedikt
    ANESTHESIA AND ANALGESIA, 2018, 127 (01): : 306 - 307
  • [5] Cardiovascular and renal benefits of sodium-glucose cotransporter-2 inhibitors: pathophysiologic mechanisms and clinical evidence
    Small, Andre M.
    Wiviott, Stephen D.
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024,
  • [6] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
    Liebers, David T.
    Ebina, Wataru
    Iosifescu, Dan V.
    HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
  • [7] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [8] Sodium-glucose cotransporter-2 inhibitors in cardiovascular disease: a gaseous solution
    Durante, William
    MEDICAL GAS RESEARCH, 2025, 15 (02): : 206 - 207
  • [9] Potential Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in the Perioperative Period Response
    Peacock, Sharon C.
    Lovshin, Julie A.
    Cherney, David Z. I.
    ANESTHESIA AND ANALGESIA, 2018, 127 (01): : 307 - 308
  • [10] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
12345